Replies to post #143337 on NanoViricides Inc. (NNVC)

[Its_lose_not_loose]

Not sure where you came up with that probability factor. It's not like a coin toss where the failure/success percentage would be 50/50. I believe the probability is much higher than 50% that NNVC won't be successful.

"Only fools listen to their hearts. Only fools get attached. We wanderers get in and get out just in time."
– Shruti Upadhaya

[arvitar]

“ Estimates of 61%, 38%, 63%, and 89% can be used as benchmarks for the probability of success for Phase I, Phase II, Phase III, and Approval, respectively, for all indications and drug classes, with an overall success rate of 13%, as based on a review of 8 publications encompassing data from 1993-2015”
https://cdn2.hubspot.net/hubfs/3828687/Alacrita_April2019/PDF/Pharmaceutical-Probability-of-Success.pdf


NNVC hasn’t even managed to get a single candidate into Phase I, after spending 15 years and $100M. This further reduces their overall probability of success from 13% to 0% for this reason:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154890209